 |
L-R: Professor Christoph Hagemeyer and Dr Be'eri Niego have published a study investigating a new drug for blood clots. |
by Anne Crawford
A team of Monash University researchers has demonstrated that an innovative drug that removes blood clots improves the outcomes of acute ischaemic stroke and has a promising safety profile.
The study, led by Professor Christoph Hagemeyer and Dr Be’eri Niego from the Australian Centre for Blood Diseases (ACBD), showed the potential of their new clot-busting agent ‘SCE5-scuPA’ in mouse stroke models.
The findings were published in ‘Blood Advances’ late last month.
